Trial Profile
Real-world study of elbasvir/grazoprevir for the treatment of hepatitis C patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record